Patient characteristics over the cross-sectional lookback period.
| All (unique patients) | Held-out cross-section | |||
| HCV | Non-HCV* | HCV | Non-HCV* | |
| Patient counts (N) | 21 508 | 28 215 073 | 4641 | 21 246 498 |
| Age (years; mean (±SD)) | 52±15.2 | 52±20.0 | 53±15.6 | 53±20.4 |
| Gender (% male) | 51.4% | 42.0% | 50.5% | 41.9% |
| HCV relevant predictors | ||||
| R-PWID (%) | 20.6% | 4.8% | 20.9% | 3.7% |
| 1946–1964 birth cohort (%) | 51.0% | 34.0% | 48.4% | 34.5% |
| Opioid usage (%) | 36.1% | 21.4% | 33.3% | 19.4% |
| Cirrhosis (%) | 1.9% | 0.2% | 1.9% | 0.3% |
| HIV/Aids (%) | 1.7% | 0.5% | 1.6% | 0.5% |
| Chronic liver disease (%) | 5.7% | 1.8% | 4.8% | 1.9% |
| Chronic disorders | ||||
| Anxiety (%) | 19.5% | 12.1% | 18.5% | 11.7% |
| Chronic lung disease (%) | 15.4% | 10.4% | 14.4% | 10.0% |
| CKD or ESRD (%) | 4.9% | 4.0% | 5.0% | 4.1% |
| Depression (%) | 18.3% | 11.1% | 17.1% | 10.6% |
| Diabetes (%) | 16.5% | 13.7% | 16.7% | 13.5% |
| Hyperlipidaemia (%) | 22.2% | 26.2% | 21.3% | 25.8% |
| Hypertension (%) | 32.3% | 27.5% | 32.9% | 27.0% |
*Counts projected to account for down-sampling.
CKD, chronic kidney disease; ESRD, end stage renal disease; HCV, hepatitis C virus; R-PWID, risk of being a person who Injects drugs.